Decoy Therapeutics, Inc. (DCOY)
0.758
+0.04
(+6.31%)
USD |
NASDAQ |
Jan 22, 16:00
0.6978
-0.06
(-7.94%)
After-Hours: 19:22
Decoy Therapeutics Excess Tax Benefit from Stock Compensation (Quarterly)
Excess Tax Benefit from Stock Compensation (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Amgen, Inc. | -- |
| CorMedix, Inc. | -- |
| Vor Biopharma, Inc. | -- |
| Humacyte, Inc. | -- |